Dr. Stephan Neuhaus

Dr. Stephan Neuhaus

Partner
Dusseldorf

Email stephan.neuhaus@​hoganlovells.com

Phone +49 211 13 68 328

Fax +49 211 13 68 100

LanguagesEnglish, French, German, Spanish

Practice groupIntellectual Property

"Stephan Neuhaus is a life sciences sage who has proved his mettle in a plethora of nullity actions before the Federal Patent Court and the Federal Court of Justice"

IAM Patent 1000, 2018

Stephan Neuhaus focuses on all aspects of patent law. He has extensive experience in litigating patents for international and national clients, especially from the pharmaceutical and chemical industries and the life sciences sector.

Stephan coordinates parallel patent infringement and revocation proceedings in the major European countries. He conducts main action infringement proceedings, preliminary injunction proceedings and inspection proceedings at the German district and appellate courts as well as nullity actions at the German Federal Patent Court and the Federal Supreme Court. His strategic advice covers questions regarding the new Unified Patent Court and the European Patent with unitary effect.

Stephan studied law and economics in Bayreuth and served his legal traineeship (Rechtsreferendariat) at the Frankfurt District Court and Frankfurt Court of Appeals. He received a postgraduate scholarship from the DFG (Deutsche Forschungsgemeinschaft) and was a member of the DFG postgraduate program Intellectual Property and the Public Domain. Stephan earned his Ph.D. in law with a thesis on secondary liability in intellectual property and unfair competition law.

Awards and recognitions

2019

Acritas Star
Acritas Stars Independently Rated Lawyers

2018

Listed as Rising Star
Managing Intellectual Property IP STARS

2017

Recommended lawyer for infringement – Bronze Band
IAM Patent 1000

Education and admissions

Education

Dr. iur., University of Bayreuth, 2010

University of Bayreuth, 2005

Memberships

German Association for the Protection of Intellectual Property (GRUR)

Representative experience

Defending market of Eli Lilly's blockbuster product Alimta® against generic market entry in preliminary injunction and main action proceedings at various German courts.

Advising major Swiss pharmaceutical company on pan-European strategy and coordinating pan-European enforcement of patents against market entry of biosimilar products.

Successfully protecting market of various major innovative pharmaceutical companies against illegal parallel importation from acceding Eastern European Member States.

Acting in various revocation proceedings at the German Federal Patent Court and at the German Federal Supreme Court.

Conducting inspection proceedings to gather information for infringement proceedings, specifically by inspecting specific sections of the pharmaceutical dossier.

Defending clients from the chemical and from the automotive industries against patent infringement allegations.

Loading data